These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18420949)

  • 1. Symptomatic intracranial atherosclerotic disease: what is the best treatment option?
    Gupta R
    Stroke; 2008 Jun; 39(6):1661-2. PubMed ID: 18420949
    [No Abstract]   [Full Text] [Related]  

  • 2. Stenting for middle cerebral artery stenosis: inevitable but when and how.
    Donnan GA; Davis SM
    Stroke; 2007 Apr; 38(4):1422. PubMed ID: 17332460
    [No Abstract]   [Full Text] [Related]  

  • 3. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of endovascular therapy for symptomatic intracranial atherosclerosis.
    Mazighi M; Yadav JS; Abou-Chebl A
    Stroke; 2008 Jun; 39(6):1766-9. PubMed ID: 18420956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective percutaneous intervention for intracranial atherosclerotic stenoses by interventional cardiologists.
    Badawi RA; White CJ; Collins TJ; Jenkins JS; Reilly JP; Grise MA; McMullan PW; Ramee SR
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):121-7. PubMed ID: 22120976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular management of intracranial atherosclerosis.
    Teleb MS; Asif K; Castonguay AC; Zaidat OO
    Neurosurg Clin N Am; 2014 Jul; 25(3):593-605. PubMed ID: 24994093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
    Turan TN; Lynn MJ; Nizam A; Lane B; Egan BM; Le NA; Lopes-Virella MF; Hermayer KL; Benavente O; White CL; Brown WV; Caskey MF; Steiner MR; Vilardo N; Stufflebean A; Derdeyn CP; Fiorella D; Janis S; Chimowitz MI;
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e51-60. PubMed ID: 22991350
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials.
    Higashida RT; Popma JJ; Apruzzese P; Zimetbaum P;
    Stroke; 2010 Feb; 41(2):e102-9. PubMed ID: 20035076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioplasty for intracranial atherosclerosis: is the treatment worse than the disease?
    Chaturvedi S; Caplan LR
    Neurology; 2003 Dec; 61(12):1647-8. PubMed ID: 14694023
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracranial angioplasty and stenting for cerebral atherosclerosis: new treatments for stroke are needed!
    Higashida RT; Meyers PM
    Neuroradiology; 2006 Jun; 48(6):367-72. PubMed ID: 16622698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.
    Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N
    Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study.
    Siddiq F; Vazquez G; Memon MZ; Suri MF; Taylor RA; Wojak JC; Chaloupka JC; Qureshi AI
    Stroke; 2008 Sep; 39(9):2505-10. PubMed ID: 18658032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management strategies in posterior circulation intracranial atherosclerotic disease.
    Povedano G; Zuberbuhler P; Lylyk P; Ameriso SF
    J Endovasc Ther; 2010 Jun; 17(3):308-13. PubMed ID: 20557167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients.
    Alurkar A; Karanam LS; Oak S; Nayak S; Sorte S
    Stroke; 2013 Jul; 44(7):2000-3. PubMed ID: 23696549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of stenting for intracranial atherosclerosis.
    Ding D; Liu KC
    Neurosurg Focus; 2011 Jun; 30(6):E15. PubMed ID: 21631216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic alternatives for symptomatic intracranial atherosclerotic disease.
    Cohen JE; Rajz G; Gomori JM; Umansky F
    Isr Med Assoc J; 2003 Oct; 5(10):731-3. PubMed ID: 14719471
    [No Abstract]   [Full Text] [Related]  

  • 17. How do we spin wingspan?
    Kallmes DF; Cloft HJ
    AJNR Am J Neuroradiol; 2008 Jan; 29(1):28-9. PubMed ID: 18039751
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to the commentary "how do we spin wingspan?".
    Levy EI; Hopkins LN; Turk AS; Fiorella DJ; Rasmussen PA; Masaryk TJ; Albuquerque FC; McDougall CG; Pride GL; Welch BG; Purdy PD; Woo HH; Niemann DB; Aagaard-Kienitz B
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):e67-8; author reply e70. PubMed ID: 18388208
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracranial stent restenosis diagnosed on routine duplex follow-up investigation.
    Gröschel K; Schnaudigel S; Buhk JH; Knauth M; Kastrup A
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):e65; author reply e66. PubMed ID: 18641084
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Turk et al and the "how do we spin wingspan?" commentary.
    Derdeyn CP; Chimowitz MI
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):e69; author reply e70. PubMed ID: 18388209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.